FDA-Cleared Biotech Innovator in Focus

Don't want emails from us anymore? Unsubscribe here *Sponsored By TD Media LLC* This information is disseminated on behalf of Medicus Pharma FDA Green Light Sparks New Momentum for Medicus Pharma (NASDAQ: MDCX) as Teverelix Advances Toward Pivotal Development in Advanced Prostate Cancer with Potential Cardiovascular Differentiation! Medicus Pharma Ltd. (NASDAQ: MDCX) has secured a major regulatory milestone with the FDA's "study may proceed" clearance for its Phase 2b dose-optimization trial of Teverelix in advanced prostate cancer—an event that significantly elevates the company's profile among emerging biotech innovators.   Teverelix, a next-generation long-acting GnRH antagonist, is designed to deliver rapid testosterone suppression without the flare associated with older agonist therapies.  With approximately 300,000 to 500,000 men in the U.S. living on androgen deprivation therapy—and cardiovascular disease accounting for roughly 30% of deaths in this population—the potential for a differentiated, cardioprotective profile could represent a powerful competitive advantage.  The Phase 2b study will evaluate sustained testosterone suppression through Day 155, setting the stage for pivotal trial discussions and positioning the asset for partnership. With a capital-efficient strategy focused on advancing assets through Phase 2 and monetizing through licensing or strategic partnerships, MDCX is aligning regulatory execution with shareholder value creation.  Management is targeting a high probability of success in the upcoming study and believes Teverelix could become a partnership candidate within the next year.  As FDA momentum builds and clinical catalysts approach, discover why MDCX is emerging as one of the most compelling small-cap biotech stories to watch in 2026 ­ Disclaimer Guy Stocks, a subsidiary of Organized Noise, LLC press releases, research reports, company profiles and other investor relations materials, publications or presentations, including web content (investor awareness services), are based on publicly available data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Furthermore, some of the content in this publication or website may contain forward-looking statements found in information made publicly available by the companies we highlight. This forward looking information fits within the meaning of Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 including statements regarding future possible events, expected continual growth of a company, the potential value of its securities, and look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. We therefore strongly encourage that you visit and review any and all financial information made publicly available by highlighted companies.  Any opinions expressed in Guy Stocks reports, company profiles, or other investor relations materials and presentations are subject to change, are expressed and given as of the date of publication, and we disclaim any obligation to advise you of any change in any information contained herein. The information contained herein is not intended to be used as the basis for investment decisions and should not be construed as advice intended to meet the particular investment needs of any investor. The information contained herein is not a representation or warranty and is not an offer or solicitation of an offer to buy or sell any security. To the fullest extent of the law, Guy Stocks, its affiliates, specialists, advisors, and partners will not be liable to any person or entity for the quality, accuracy, completeness, reliability or timeliness of the information provided, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information provided to any person or entity (including but not limited to lost profits, loss of opportunities, trading losses and damages that may result from any inaccuracy or incompleteness of this information). Stock market investing is inherently risky. Guy Stocks and its affiliates are not responsible for any gains or losses that result from the opinions expressed in press releases, on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov. and/or the Ontario Securities Commission ("OSC") at www.osc.gov.on.ca. and/or the British Columbia Securities Commission ("BCSC") at https://www.bcsc.bc.ca/. Income Disclosures Guy Stocks and Organized Noise LLC have been retained by TD Media LLC to perform promotional and advertising services for a limited time for Medicus Pharma (NASDAQ: MDCX), and has received cash compensation of $25,000 beginning on 3/3/26 for the period ended 3/3/26 from TD Media LLC related to the engagement of investor awareness services for Medicus Pharma (NASDAQ: MDCX). Guy Stocks and Organized Noise LLC and its affiliates may buy and sell shares of securities or options and warrants of the companies mentioned in this publication or website at any time but are not and will not at any time become affiliates or owners of more than 5% of the issued and outstanding stock of the highlighted companies. Guy Stocks, Organized Noise LLC and its beneficial owners and affiliates, do not own shares in Medicus Pharma (NASDAQ: MDCX). Investor awareness services and programs are designed to help small-cap companies communicate their investment characteristics. Guy Stocks investor awareness services include the preparation of a research profile(s), multimedia marketing, and other awareness services based on the publicly available information of our clients and prepared by our partners.    1389 Center Dr Park City UT 84098 USA   UNSUBSCRIBE ­